John Tolsma
John Tolsma
RES Group
Verified email at resgroupinc.com
Title
Cited by
Cited by
Year
Efficient sensitivity analysis of large-scale differential-algebraic systems
WF Feehery, JE Tolsma, PI Barton
Applied Numerical Mathematics 25 (1), 41-54, 1997
2841997
DAEPACK: An open modeling environment for legacy models
J Tolsma, PI Barton
Industrial & Engineering Chemistry Research 39 (6), 1826-1839, 2000
1252000
Optimal design and operation of a natural gas tri-reforming reactor for DME synthesis
W Cho, T Song, A Mitsos, JT McKinnon, GH Ko, JE Tolsma, D Denholm, ...
Catalysis Today 139 (4), 261-267, 2009
1032009
On upgrading the numerics in combustion chemistry codes
DA Schwer, JE Tolsma, WH Green Jr, PI Barton
Combustion and Flame 128 (3), 270-291, 2002
782002
Rigorous valid ranges for optimally reduced kinetic models
OO Oluwole, B Bhattacharjee, JE Tolsma, PI Barton, WH Green
Combustion and Flame 146 (1-2), 348-365, 2006
772006
On computational differentiation
JE Tolsma, PI Barton
Computers & chemical engineering 22 (4-5), 475-490, 1998
681998
Hidden discontinuities and parametric sensitivity calculations
JE Tolsma, PI Barton
SIAM Journal on Scientific Computing 23 (6), 1861-1874, 2002
552002
Construction of convex relaxations using automated code generation techniques
EP Gatzke, JE Tolsma, PI Barton
Optimization and Engineering 3 (3), 305-326, 2002
512002
Symbolic incorporation of external procedures into process modeling environments
JE Tolsma, JA Clabaugh, PI Barton
Industrial & engineering chemistry research 41 (16), 3867-3876, 2002
482002
Rapid Method To Determine Intracellular Drug Concentrations in Cellular Uptake Assays: Application to Metformin in Organic Cation Transporter 1–Transfected Human Embryonic …
HC Chien, AA Zur, TS Maurer, SW Yee, J Tolsma, P Jasper, DO Scott, ...
Drug Metabolism and Disposition 44 (3), 356-364, 2016
422016
Bridging the gap between in vitro and in vivo: dose and schedule predictions for the ATR inhibitor AZD6738
S Checkley, L MacCallum, J Yates, P Jasper, H Luo, J Tolsma, ...
Scientific reports 5 (1), 1-12, 2015
412015
Preclinical to clinical translation of antibody-drug conjugates using PK/PD modeling: a retrospective analysis of inotuzumab ozogamicin
AM Betts, N Haddish-Berhane, J Tolsma, P Jasper, LE King, Y Sun, ...
The AAPS journal 18 (5), 1101-1116, 2016
272016
Computation of heteroazeotropes. Part I: Theory
JE Tolsma, PI Barton
Chemical engineering science 55 (18), 3817-3834, 2000
222000
Computation of heteroazeotropes. Part II: Efficient calculation of changes in phase equilibrium structure
JE Tolsma, PI Barton
Chemical engineering science 55 (18), 3835-3853, 2000
152000
Systems pharmacology model of gastrointestinal damage predicts species differences and optimizes clinical dosing schedules
H Shankaran, A Cronin, J Barnes, P Sharma, J Tolsma, P Jasper, ...
CPT: pharmacometrics & systems pharmacology 7 (1), 26-33, 2018
142018
Efficient calculation of sparse Jacobians
JE Tolsma, PI Barton
SIAM Journal on Scientific Computing 20 (6), 2282-2296, 1999
131999
Analysis of heteroazenotropic systems
JE Tolsma
Massachusetts Institute of Technology, 1999
111999
Analysis of heteroazenotropic systems
JE Tolsma
Massachusetts Institute of Technology, 1999
111999
Quantitative systems pharmacology modeling of acid sphingomyelinase deficiency and the enzyme replacement therapy olipudase alfa is an innovative tool for linking …
CD Kaddi, B Niesner, R Baek, P Jasper, J Pappas, J Tolsma, J Li, ...
CPT: pharmacometrics & systems pharmacology 7 (7), 442-452, 2018
82018
ABACUSS II: Advanced modeling environment and embedded simulator
JA Clabaugh, JE Tolsma, PI Barton
Technical report, Massachusetts Institute of Technology, 2000. http://yoric …, 1999
81999
The system can't perform the operation now. Try again later.
Articles 1–20